Munich - Delayed Quote EUR
Amneal Pharmaceuticals Inc (2DT.MU)
6.45
0.00
(0.00%)
As of 8:03:53 AM GMT+2. Market Open.
Loading Chart for 2DT.MU
- Previous Close
6.45 - Open
6.45 - Bid 6.40 x --
- Ask 6.55 x --
- Day's Range
6.45 - 6.45 - 52 Week Range
5.95 - 8.65 - Volume
0 - Avg. Volume
0 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Aug 8, 2025 - Aug 13, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 2DT.MU
View MorePerformance Overview: 2DT.MU
Trailing total returns as of 6/3/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
2DT.MU
14.00%
S&P 500 (^GSPC)
0.96%
1-Year Return
2DT.MU
4.03%
S&P 500 (^GSPC)
12.39%
3-Year Return
2DT.MU
89.71%
S&P 500 (^GSPC)
44.53%
5-Year Return
2DT.MU
46.59%
S&P 500 (^GSPC)
90.15%
Compare To: 2DT.MU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
6.45
0.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
26.80
-0.74%
Mkt Cap EUR 310.821M
Industry Drug Manufacturers—Specialty & Generic
1.8800
-0.53%
Mkt Cap AUD 104.291M
Industry Drug Manufacturers—Specialty & Generic
Mkt Cap undefined -
Industry -
2.8300
-0.70%
Mkt Cap NZD 298.868M
Industry Drug Manufacturers—Specialty & Generic
64.70
0.00%
Mkt Cap GBp 349.746M
Industry Drug Manufacturers—Specialty & Generic
Statistics: 2DT.MU
View MoreValuation Measures
As of 6/2/2025
Market Cap
2.05B
Enterprise Value
4.27B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.81
Price/Book (mrq)
--
Enterprise Value/Revenue
1.71
Enterprise Value/EBITDA
8.83
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--